SCHEMBL21029427

SCHEMBL21029427

Cc1cc(C[C@H](N)C(=O)OC(C)(C)C)ccc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.45
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
MMP13 P45452 1/20 0.38
LTA4H P09960 1/20 0.38
APP P05067 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
NFKB1 P19838 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.36
PMP22 Q01453 1/20 0.36
NLRP3 Q96P20 1/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21029611 0.89 SLC7A5 (0.45) SLC7A5HDAC1LTA4HAPPALDH1A1
SCHEMBL21029376 0.87 SLC7A5 (0.48) SLC7A5LTA4HALDH1A1CYP3A4CYP1A2
SCHEMBL3745863 0.85 SLC7A5 (0.44) SLC7A5LTA4HAPPALDH1A1CYP3A4
SCHEMBL3745868 0.85 SLC7A5 (0.44) SLC7A5LTA4HAPPALDH1A1CYP3A4
SCHEMBL24899365 0.85 APP (0.41) HDAC3HDAC1HDAC2HDAC8MMP13
SCHEMBL5367312 0.85 ALDH1A1 (0.51) SLC7A5HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL27548705 0.83 ALDH1A1 (0.53) SLC7A5HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL5367308 0.83 ALDH1A1 (0.53) SLC7A5HDAC3HDAC1HDAC2HDAC8
SCHEMBL19088473 0.83 SLC7A5 (0.44) SLC7A5LTA4HAPPALDH1A1CYP3A4
SCHEMBL29551946 0.83 SLC7A5 (0.44) SLC7A5LTA4HAPPALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301286-B2 Piperazine derivative ASTELLAS PHARMA INC. (JP) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301286-B2 Piperazine derivative GPR4, MC4R, TRPC4 SLC7A5 2250/4885HDAC3 867/4885HDAC1 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.